Opposing effects of RAS on p53: Transcriptional activation of mdm2 and induction of p19(ARF)

Stefan Ries, Carola Biederer, Douglas Woods, Ohad Shifman, Senji Shirasawa, Takehiko Sasazuki, Martin McMahon, Moshe Oren, Frank McCormick

研究成果: Contribution to journalArticle査読

318 被引用数 (Scopus)

抄録

Mdm2 acts as a major regulator of the tumor suppressor p53 by targeting its destruction. Here, we show that the mdm2 gene is also regulated by the Ras-driven Raf/MEK/MAP kinase pathway, in a p53-independent manner. Mdm2 induced by activated Raf degrades p53 in the absence of the Mdm2 inhibitor p19(ARF). This regulatory pathway accounts for the observation that cells transformed by oncogenic Ras are more resistant to p53-dependent apoptosis following exposure to DNA damage. Activation of the Ras-induced Raf/MEK/MAP kinase may therefore play a key role in suppressing p53 during tumor development and treatment. In primary cells, Raf also activates the Mdm2 inhibitor p19(ARF). Levels of p53 are therefore determined by opposing effects of Raf-induced p19(ARF) and Mdm2.

本文言語英語
ページ(範囲)321-330
ページ数10
ジャーナルCell
103
2
DOI
出版ステータス出版済み - 10 13 2000

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

フィンガープリント 「Opposing effects of RAS on p53: Transcriptional activation of mdm2 and induction of p19(ARF)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル